Cartesian Therapeutics Inc (RNAC)
SG&A Expense Growth
4.45%
Fiscal year · Period ending:
RNAC SG&A Expense Growth
Latest reported4.45%period ending
Latest reported4.45%period ending
RNAC FY SG&A Growth (YoY) (0.00% → 4.45%)
Latest values, visible window
High-resolution chart · PNG
RNAC sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.4546% | |
| -25.5229% | |
| 69.5164% | |
| 13.965% | |
| 10.7069% | |
| 15.4006% | |
| -5.0629% | |
| -4.4977% | |
| 47.5712% | |
| 68.0016% | |
| -8.3239% | |
| 0% |